Exact Mass: 295.1267

Exact Mass Matches: 295.1267

Found 205 metabolites which its exact mass value is equals to given mass value 295.1267, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Xylopine

(12R)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0{2,6}.0{8,20}.0{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene

C18H17NO3 (295.1208)


Xylopine, also known as (-)-xylopine, is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. Xylopine is practically insoluble (in water) and a very strong basic compound (based on its pKa). Xylopine can be found in cherimoya and custard apple, which makes xylopine a potential biomarker for the consumption of these food products. Xylopine is an antimicrobial benzylisoquinoline alkaloid . Xylopine is an aporphine alkaloid. Xylopine is a natural product found in Dasymaschalon longiflorum, Annona muricata, and other organisms with data available.

   

Sumatriptan

1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide

C14H21N3O2S (295.1354)


Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve. Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraines. Sumatriptan (Imitrex, Imigran, Imigran Recovery) is a triptan drug including a sulfonamide group which was originally developed by Glaxo for the treatment of migraine headaches. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve.; Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC50s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT1D, 5-HT1B and 5-HT1F receptors, respectively. Sumatriptan can be used for migraine headache research[1][2][3][4].

   

NSC627046

N6,N6-Dimethyladenosine

C12H17N5O4 (295.128)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

Mecambrine

(-)-Mecambrine

C18H17NO3 (295.1208)


   

(+)-Mecambroline

(+)-Mecambroline

C18H17NO3 (295.1208)


   

Pukateine

CHEMBL258370

C18H17NO3 (295.1208)


   

Japonine

3,6-dimethoxy-1-methyl-2-phenyl-quinolin-4-one

C18H17NO3 (295.1208)


   

GYKI 52895

4-(8-METHYL-8,9-DIHYDRO-7H-[1,3]DIOXOLO[4,5:4,5]BENZO[1,2-D][1,2]DIAZEPIN-5-YL)ANILINE

C17H17N3O2 (295.1321)


   

Norfluoxetine

3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine

C16H16F3NO (295.1184)


Norfluoxetine is a metabolite of fluoxetine. (S)-Norfluoxetine, also known as seproxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the most important active metabolite of the widely used antidepressant fluoxetine but little is known about its pharmacological actions. Seproxetine was being investigated by Eli Lilly and Company as an antidepressant, however, a cardiac side effect was noted and development was discontinued (Wikipedia).

   

7-Hydroxyheptaphylline

2,7-Dihydroxy-1-(3-methyl-2-butenyl)-9H-carbazole-3-carboxaldehyde, 9ci

C18H17NO3 (295.1208)


7-Hydroxyheptaphylline is found in fruits. 7-Hydroxyheptaphylline is an alkaloid from root bark of Clausena lansium (wampee). Alkaloid from root bark of Clausena lansium (wampee). 7-Hydroxyheptaphylline is found in fruits.

   

Tyrosyl-Asparagine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoate

C13H17N3O5 (295.1168)


Tyrosyl-Asparagine is a dipeptide composed of tyrosine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Asparaginyl-Tyrosine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoate

C13H17N3O5 (295.1168)


Asparaginyl-Tyrosine is a dipeptide composed of asparagine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

2-Methacryloyloxyethyl phosphorylcholine

trimethyl[2-({2-[(2-methylprop-2-enoyl)oxy]ethyl phosphono}oxy)ethyl]azanium

C11H22NO6P (295.1185)


   

H-Tyr-gly-gly-OH

2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxyethylidene)amino]acetate

C13H17N3O5 (295.1168)


   

Glycyl-tyrosyl-glycine

2-[2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]acetic acid

C13H17N3O5 (295.1168)


   

Indobufen

2-[4-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)phenyl]butanoic acid

C18H17NO3 (295.1208)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

N(6),O(2)-Dimethyladenosine

2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)-9H-purin-9-yl]oxolan-3-ol

C12H17N5O4 (295.128)


   

N2-Ethyl-2'-deoxyguanosine

2-(ethylamino)-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C12H17N5O4 (295.128)


   

N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide

N-(oxo-5,6-Dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride

C17H17N3O2 (295.1321)


   
   
   

Pachypodanthine

Pachypodanthine

C18H17NO3 (295.1208)


   

3,3-Dimethyl-10-hydroxy-1,2,3,11-tetrahydropyrano[3,2-a]carbazole-5-carbaldehyde

3,3-Dimethyl-10-hydroxy-1,2,3,11-tetrahydropyrano[3,2-a]carbazole-5-carbaldehyde

C18H17NO3 (295.1208)


   
   

2-O-beta-D-glucopyranosyl 1,4-Dideoxy-1,4-imino-D-arabinitol

1,4-Dideoxy-1,4-imino-(2-O-beta-D-glucopyranosyl)-D-arabinitol

C11H21NO8 (295.1267)


   

Remeroline

N-Methylanolobine

C18H17NO3 (295.1208)


   

MEGxp0_002052

MEGxp0_002052

C18H17NO3 (295.1208)


   
   

4-(6,7-Dimethoxyisoquinoline-1-ylmethyl)phenol

4-(6,7-Dimethoxyisoquinoline-1-ylmethyl)phenol

C18H17NO3 (295.1208)


   

Pethoxamid

Pethoxamide

C16H22ClNO2 (295.1339)


CONFIDENCE standard compound; INTERNAL_ID 2535 CONFIDENCE standard compound; INTERNAL_ID 8399 CONFIDENCE standard compound; INTERNAL_ID 4062 CONFIDENCE standard compound; EAWAG_UCHEM_ID 700

   

Isoxadifen-ethyl

4,5-dihydro-5,5-diphenyl-1,2-oxazole-3-carboxylic acid, ethyl ester

C18H17NO3 (295.1208)


CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9548; ORIGINAL_PRECURSOR_SCAN_NO 9545 CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9558; ORIGINAL_PRECURSOR_SCAN_NO 9557 CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9573; ORIGINAL_PRECURSOR_SCAN_NO 9571 CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9589; ORIGINAL_PRECURSOR_SCAN_NO 9588 CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9589; ORIGINAL_PRECURSOR_SCAN_NO 9587 CONFIDENCE standard compound; INTERNAL_ID 1336; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9601; ORIGINAL_PRECURSOR_SCAN_NO 9599 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3168

   

2-Phenyl-3-(3,4,5-trimethoxyphenyl)acrylonitrile

2-Phenyl-3-(3,4,5-trimethoxyphenyl)acrylonitrile

C18H17NO3 (295.1208)


   
   
   

Murrayaquinone E

Murrayaquinone E

C18H17NO3 (295.1208)


   
   

5-acetamido-3,5-dideoxy-beta-D-glycero-D-galacto-nonulopyranose|5-Acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-nonulo-pyranose

5-acetamido-3,5-dideoxy-beta-D-glycero-D-galacto-nonulopyranose|5-Acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-nonulo-pyranose

C11H21NO8 (295.1267)


   

1,4-dideoxy-1,4-imino-(5-O-beta-D-glucopyranosyl)-D-arabinitol

1,4-dideoxy-1,4-imino-(5-O-beta-D-glucopyranosyl)-D-arabinitol

C11H21NO8 (295.1267)


   

(+)-nornuciferine

(+)-nornuciferine

C18H17NO3 (295.1208)


   

6N-Me-2-Methyladenosine

6N-Me-2-Methyladenosine

C12H17N5O4 (295.128)


   

(6aR)-4,5,6a,7-tetrahydro-2-hydroxy-1-methoxy-6H-dibenzo[de,g]quinoline-6-carbaldehyde|kachirachiranine|N-formylasimilobine

(6aR)-4,5,6a,7-tetrahydro-2-hydroxy-1-methoxy-6H-dibenzo[de,g]quinoline-6-carbaldehyde|kachirachiranine|N-formylasimilobine

C18H17NO3 (295.1208)


   

4-(7-hydroxy-3-methoxy-6-methyl-9H-carbazol-4-yl)but-3-en-2-one

4-(7-hydroxy-3-methoxy-6-methyl-9H-carbazol-4-yl)but-3-en-2-one

C18H17NO3 (295.1208)


   

Clausenawalline H

Clausenawalline H

C18H17NO3 (295.1208)


   
   

2,8-dihydroxy-7-(3-methylbut-2-en-1-yl)-9H-carbazole-3-carbaldehyde|excavatine A

2,8-dihydroxy-7-(3-methylbut-2-en-1-yl)-9H-carbazole-3-carbaldehyde|excavatine A

C18H17NO3 (295.1208)


   

PC-2000-53-503-15

PC-2000-53-503-15

C18H17NO3 (295.1208)


   

(+)-norstephalagine|(-)-norstephalagine|noestephalagine|Norstephalagin|Norstephalagine

(+)-norstephalagine|(-)-norstephalagine|noestephalagine|Norstephalagin|Norstephalagine

C18H17NO3 (295.1208)


   
   
   

H-TYR-GLY-GLY-OH

H-TYR-GLY-GLY-OH

C13H17N3O5 (295.1168)


   

Glycyl-tyrosyl-glycine

Glycyl-tyrosyl-glycine

C13H17N3O5 (295.1168)


   

Norfluoxetine

Norfluoxetine

C16H16F3NO (295.1184)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 335 CONFIDENCE standard compound; INTERNAL_ID 2112

   

Propranolol HCl

Propranolol hydrochloride

C16H22ClNO2 (295.1339)


Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].

   

Seproxetine

NFL_296.1257_14.5

C16H16F3NO (295.1184)


CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1000 C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

sumatriptan

sumatriptan

C14H21N3O2S (295.1354)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC50s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT1D, 5-HT1B and 5-HT1F receptors, respectively. Sumatriptan can be used for migraine headache research[1][2][3][4].

   

Pachypodantine

Pachypodantine

C18H17NO3 (295.1208)


   

O6-Ethyl-deoxyguanosine

O6-Ethyl-deoxyguanosine

C12H17N5O4 (295.128)


   

1-Ethyl-deoxyguanosine

1-Ethyl-deoxyguanosine

C12H17N5O4 (295.128)


   

N2-Ethyl-deoxyguanosine

N2-Ethyl-deoxyguanosine

C12H17N5O4 (295.128)


   
   

8-Hydroxydesmethylondansetron

8-Hydroxydesmethylondansetron

C17H17N3O2 (295.1321)


   

7-Hydroxydesmethylondansetron

7-Hydroxydesmethylondansetron

C17H17N3O2 (295.1321)


   

6-Hydroxydesmethylondansetron

6-Hydroxydesmethylondansetron

C17H17N3O2 (295.1321)


   
   
   
   
   

3-Pyrrolidineacetic acid, 5-oxo-4,4-diphenyl- (9CI)

3-Pyrrolidineacetic acid, 5-oxo-4,4-diphenyl- (9CI)

C18H17NO3 (295.1208)


   

Desmethylfluoxetine

Desmethylfluoxetine

C16H16F3NO (295.1184)


   

(2R,4R)-tert-butyl 4-(hydroxymethyl)-2-phenylthiazolidine-3-carboxylate

(2R,4R)-tert-butyl 4-(hydroxymethyl)-2-phenylthiazolidine-3-carboxylate

C15H21NO3S (295.1242)


   

Asn-tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C13H17N3O5 (295.1168)


A dipeptide composed of L-asparagine and L-tyrosine joined by a peptide linkage.

   

Tyr-asn

2-(2-amino-3-carbamoylpropanamido)-3-(4-hydroxyphenyl)propanoic acid

C13H17N3O5 (295.1168)


   

7-Hydroxyheptaphylline

2,7-Dihydroxy-1-(3-methyl-2-butenyl)-9H-carbazole-3-carboxaldehyde, 9ci

C18H17NO3 (295.1208)


A natural product found in Clausena harmandiana.

   

3-(PYRROLIDINE-1-CARBONYL)-[1,1-BIPHENYL]-2-CARBOXYLIC ACID

3-(PYRROLIDINE-1-CARBONYL)-[1,1-BIPHENYL]-2-CARBOXYLIC ACID

C18H17NO3 (295.1208)


   

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

C12H17N5O4 (295.128)


   

fmoc-ala-aldehyde

fmoc-ala-aldehyde

C18H17NO3 (295.1208)


   

(3-CYCLOPROPANECARBONYL-PHENYL)-CARBAMIC ACID BENZYL ESTER

(3-CYCLOPROPANECARBONYL-PHENYL)-CARBAMIC ACID BENZYL ESTER

C18H17NO3 (295.1208)


   

methyl-3-isocyano-3-(4-benzyloxyphenyl)propionate

methyl-3-isocyano-3-(4-benzyloxyphenyl)propionate

C18H17NO3 (295.1208)


   

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

C12H17N5O4 (295.128)


   

1-BOC-4-(4-CHLOROPHENYL)PIPERIDINE

1-BOC-4-(4-CHLOROPHENYL)PIPERIDINE

C16H22ClNO2 (295.1339)


   

(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-phenylmethanone

(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-phenylmethanone

C17H17N3O2 (295.1321)


   

1-HYDROXYBENZOTRIAZOLEHYDRATE

1-HYDROXYBENZOTRIAZOLEHYDRATE

C17H17N3O2 (295.1321)


   

tyr-gly-gly

H-TYR-GLY-GLY-OH

C13H17N3O5 (295.1168)


A tripeptide composed of one L-tyrosine and two glycine residues joined in sequence.

   

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-P-TOLYL-ACETAMIDE

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-P-TOLYL-ACETAMIDE

C17H17N3O2 (295.1321)


   

(5-AMINO-2-METHOXY-PHENYL)-CARBAMICACIDTERT-BUTYLESTER

(5-AMINO-2-METHOXY-PHENYL)-CARBAMICACIDTERT-BUTYLESTER

C17H17N3O2 (295.1321)


   

Deacetyl Linezolid

Deacetyl Linezolid

C14H18FN3O3 (295.1332)


   

3-(3-PHENYLAMINO-PROPYL)-1H-QUINAZOLINE-2,4-DIONE

3-(3-PHENYLAMINO-PROPYL)-1H-QUINAZOLINE-2,4-DIONE

C17H17N3O2 (295.1321)


   

Dexpropranolol hydrochloride

(R)-Propranolol hydrochloride

C16H22ClNO2 (295.1339)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents (R)-Propranolol hydrochloride is a less active enantiomer of the?β-adrenoceptor antagonist?propranolol (HY-B0573). Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1].

   

(R)-(+)-propranolol

(R)-(+)-propranolol

C16H22ClNO2 (295.1339)


   

1-[2-(2-METHOXY-PHENOXY)-ETHYL]-1H-INDOLE-3-CARBALDEHYDE

1-[2-(2-METHOXY-PHENOXY)-ETHYL]-1H-INDOLE-3-CARBALDEHYDE

C18H17NO3 (295.1208)


   

(2S,4R)-1-(Diisopropoxyphosphoryl)-4-hydroxypyrrolidine-2-carboxylic acid

(2S,4R)-1-(Diisopropoxyphosphoryl)-4-hydroxypyrrolidine-2-carboxylic acid

C11H22NO6P (295.1185)


   

2-(4-methylbenzoyl)-3,4-dihydro-1H-isoquinoline-3-carboxylic acid

2-(4-methylbenzoyl)-3,4-dihydro-1H-isoquinoline-3-carboxylic acid

C18H17NO3 (295.1208)


   

N-[1,1-biphenyl]-4-yl-1-naphthalenamine

N-[1,1-biphenyl]-4-yl-1-naphthalenamine

C22H17N (295.1361)


   

5-Benzyloxyindole-3-acetic acid methyl ester

5-Benzyloxyindole-3-acetic acid methyl ester

C18H17NO3 (295.1208)


   

Fmoc-D-Ala-aldehyde

Fmoc-D-Ala-aldehyde

C18H17NO3 (295.1208)


   

(R)-Norfluoxetine

(R)-Norfluoxetine

C16H16F3NO (295.1184)


   

Choline Citrate (1:1) (Salt)

Choline Citrate (1:1) (Salt)

C11H21NO8 (295.1267)


   

H-Gly-Tyr-Gly-OH

H-Gly-Tyr-Gly-OH

C13H17N3O5 (295.1168)


   

(4S)-1-Benzoyl-4-phenyl-L-proline

(4S)-1-Benzoyl-4-phenyl-L-proline

C18H17NO3 (295.1208)


   

H-Gly-Gly-Tyr-OH

Glycylglycyl-L-tyrosine

C13H17N3O5 (295.1168)


   

Entecavir hydrate

Entecavir monohydrate

C12H17N5O4 (295.128)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent Entecavir monohydrate (BMS200475 monohydrate; SQ34676 monohydrate) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.

   

6-methyl-2,4-diphenylquinoline

6-methyl-2,4-diphenylquinoline

C22H17N (295.1361)


   

3-(2-(BENZYLAMINO)ETHYL)QUINAZOLINE-2,4(1H,3H)-DIONE

3-(2-(BENZYLAMINO)ETHYL)QUINAZOLINE-2,4(1H,3H)-DIONE

C17H17N3O2 (295.1321)


   

(9-ETHYL-9H-CARBAZOL-3-YLMETHYL)-HYDRAZINE

(9-ETHYL-9H-CARBAZOL-3-YLMETHYL)-HYDRAZINE

C18H17NO3 (295.1208)


   

2-CARBETHOXY-4-BENZYLOXYINDOLE

2-CARBETHOXY-4-BENZYLOXYINDOLE

C18H17NO3 (295.1208)


   

Benzeneacetonitrile, a-(3-chloropropyl)-3,4-dimethoxy-a-(1-methylethyl)-

Benzeneacetonitrile, a-(3-chloropropyl)-3,4-dimethoxy-a-(1-methylethyl)-

C16H22ClNO2 (295.1339)


   

6-METHYL-4-PIPERAZINO-2-(TRIFLUOROMETHYL)QUINOLINE

6-Methyl-4-(piperazin-1-yl)-2-(trifluoromethyl)quinoline

C15H16F3N3 (295.1296)


   

Propranolol hydrochloride

Propranolol hydrochloride

C16H22ClNO2 (295.1339)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].

   

4-AMINO-BENZOIC ACID 3-(1H-BENZOIMIDAZOL-2-YL)-PROPYL ESTER

4-AMINO-BENZOIC ACID 3-(1H-BENZOIMIDAZOL-2-YL)-PROPYL ESTER

C17H17N3O2 (295.1321)


   

3-(5,6-dimethyl-1H-indol-2-yl)-4-methoxybenzoic acid

3-(5,6-dimethyl-1H-indol-2-yl)-4-methoxybenzoic acid

C18H17NO3 (295.1208)


   

3,3-difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one

3,3-difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one

C14H16BF2NO3 (295.1191)


   

Sulodexide

Adenosine, N-methyl-2-O-methyl-

C12H17N5O4 (295.128)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AB - Heparin group D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D006401 - Hematologic Agents > D000925 - Anticoagulants D009676 - Noxae > D000963 - Antimetabolites D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D007004 - Hypoglycemic Agents

   

1,2,3-Triphenyl-1H-pyrrole

1,2,3-Triphenyl-1H-pyrrole

C22H17N (295.1361)


   

Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride

Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride

C16H22ClNO2 (295.1339)


   

(S)-3-(3-ACETYLPHENYL)-4-ETHYLOXAZOLIDIN-2-ONE

(S)-3-(3-ACETYLPHENYL)-4-ETHYLOXAZOLIDIN-2-ONE

C18H17NO3 (295.1208)


   

(S)-(-)-PROPRANOLOL HYDROCHLORIDE

(S)-(-)-PROPRANOLOL HYDROCHLORIDE

C16H22ClNO2 (295.1339)


(S)-(-)-Propranolol hydrochloride is a β-adrenergic receptor antagonist with log Kd?values of -8.16, -9.08, and -6.93 for β1, β2, and β3, respectively. (S)-(-)-Propranolol hydrochloride the active enantiomer of propranolol and can be s used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[2].

   

2-AMINO-1,4-DIHYDRO-4-PHENYL-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, ETHYL ESTER

2-AMINO-1,4-DIHYDRO-4-PHENYL-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, ETHYL ESTER

C17H17N3O2 (295.1321)


   

(9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate

(9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate

C18H17NO3 (295.1208)


   

5-Benzyloxyindole-3-carboxylic acid ethyl ester

5-Benzyloxyindole-3-carboxylic acid ethyl ester

C18H17NO3 (295.1208)


   

1-Benzyl 3-methyl 3-fluoro-1,3-piperidinedicarboxylate

1-Benzyl 3-methyl 3-fluoro-1,3-piperidinedicarboxylate

C15H18FNO4 (295.122)


   

Celgosivir hydrochloride

Celgosivir hydrochloride

C12H22ClNO5 (295.1186)


C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor

   

2-Deoxy-N-ethylguanosine

2-Deoxy-N-ethylguanosine

C12H17N5O4 (295.128)


   

O(6)-Ethyl-2-deoxyguanosine

O(6)-Ethyl-2-deoxyguanosine

C12H17N5O4 (295.128)


   

1-[2-(4-Phenylmethoxyphenoxy)ethyl]-1,2,4-triazole

1-[2-(4-Phenylmethoxyphenoxy)ethyl]-1,2,4-triazole

C17H17N3O2 (295.1321)


   

furan-2-yl-[4-(1H-indol-4-yl)piperazin-1-yl]methanone

furan-2-yl-[4-(1H-indol-4-yl)piperazin-1-yl]methanone

C17H17N3O2 (295.1321)


   

5-Methyl-2-(2-phenoxyethyl)-4-phenyl-1,2,4-triazol-3-one

5-Methyl-2-(2-phenoxyethyl)-4-phenyl-1,2,4-triazol-3-one

C17H17N3O2 (295.1321)


   

(E)-N-benzyl-2-cyano-3-[5-(dimethylamino)furan-2-yl]prop-2-enamide

(E)-N-benzyl-2-cyano-3-[5-(dimethylamino)furan-2-yl]prop-2-enamide

C17H17N3O2 (295.1321)


   

Indobufen

Indobufen

C18H17NO3 (295.1208)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   
   

Iridium hexammine ion

Iridium hexammine ion

H18IrN6+3 (295.1222)


   

2-[[(4-Ethylphenyl)-oxomethyl]amino]-4-(methylthio)butanoic acid methyl ester

2-[[(4-Ethylphenyl)-oxomethyl]amino]-4-(methylthio)butanoic acid methyl ester

C15H21NO3S (295.1242)


   

7-Hydroxy-2-methyl-6-propyl-3-(2-pyridinyl)-1-benzopyran-4-one

7-Hydroxy-2-methyl-6-propyl-3-(2-pyridinyl)-1-benzopyran-4-one

C18H17NO3 (295.1208)


   
   

N-acetyl-beta-neuraminol

N-acetyl-beta-neuraminol

C11H21NO8 (295.1267)


   

L-Tyrosyl-L-asparagine

L-Tyrosyl-L-asparagine

C13H17N3O5 (295.1168)


   

N-{4-[3-(2-methoxyphenyl)acryloyl]phenyl}acetamide

N-{4-[3-(2-methoxyphenyl)acryloyl]phenyl}acetamide

C18H17NO3 (295.1208)


   

3-[1-(2-Furanylmethyl)-5-phenyl-2-pyrrolyl]propanoic acid

3-[1-(2-Furanylmethyl)-5-phenyl-2-pyrrolyl]propanoic acid

C18H17NO3 (295.1208)


   

Hydron;1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;chloride

Hydron;1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;chloride

C16H22ClNO2 (295.1339)


   

N-acetylneuraminol

N-acetylneuraminol

C11H21NO8 (295.1267)


   

3-Hydroxy-1-methyl-4,5-diphenylpiperidine-2,6-dione

3-Hydroxy-1-methyl-4,5-diphenylpiperidine-2,6-dione

C18H17NO3 (295.1208)


   

6-Methyl-2-(p-acetamidophenyl)-4-chromanone

6-Methyl-2-(p-acetamidophenyl)-4-chromanone

C18H17NO3 (295.1208)


   

Xylopine

(12R)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0{2,6}.0{8,20}.0{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene

C18H17NO3 (295.1208)


Xylopine is an aporphine alkaloid. Xylopine is a natural product found in Dasymaschalon longiflorum, Annona muricata, and other organisms with data available.

   

N,N-Dimethyladenosine

N6,N6-Dimethyladenosine

C12H17N5O4 (295.128)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

(+)-Mecambroline

(+)-Mecambroline

C18H17NO3 (295.1208)


   

PJ34

N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide

C17H17N3O2 (295.1321)


   

Tyrosylasparagine

Tyrosylasparagine

C13H17N3O5 (295.1168)


   

Asparaginyl-Tyrosine

Asparaginyl-Tyrosine

C13H17N3O5 (295.1168)


   

Tyr-Gly-Gly zwitterion

Tyr-Gly-Gly zwitterion

C13H17N3O5 (295.1168)


A tripeptide zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of Tyr-Gly-Gly. Major microspecies at pH 7.3.

   

N(6),N(6)-Dimethyladenosine

N(6),N(6)-Dimethyladenosine

C12H17N5O4 (295.128)


   
   

N6,2′-O-Dimethyladenosine

N6,2′-O-Dimethyladenosine

C12H17N5O4 (295.128)


N6,2′-O-Dimethyladenosine, a substrate of fat mass and obesity-associated gene (FTO), is a reversible modification widely occurred on varied RNA molecules. N6,2′-O-Dimethyladenosine can regulate obesity[1][2].

   

N6-Ethyladenosine

N6-Ethyladenosine

C12H17N5O4 (295.128)


N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1]. N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1].

   

(11r,12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

(11r,12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

C18H17NO3 (295.1208)


   

2-hydroxy-1-(2-hydroxy-3-methylbut-3-en-1-yl)-9h-carbazole-3-carbaldehyde

2-hydroxy-1-(2-hydroxy-3-methylbut-3-en-1-yl)-9h-carbazole-3-carbaldehyde

C18H17NO3 (295.1208)


   

10-hydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

10-hydroxy-3,3-dimethyl-1h,2h,11h-pyrano[3,2-a]carbazole-5-carbaldehyde

C18H17NO3 (295.1208)


   

7-hydroxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazole-1,4-dione

7-hydroxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazole-1,4-dione

C18H17NO3 (295.1208)


   

2-[(3,4-dihydroxypyrrolidin-2-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3,4-dihydroxypyrrolidin-2-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C11H21NO8 (295.1267)


   

(1r)-6-methoxy-9-oxa-2-azapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-5(18),6,8(17),11(16),12,14-hexaen-7-ol

(1r)-6-methoxy-9-oxa-2-azapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-5(18),6,8(17),11(16),12,14-hexaen-7-ol

C18H17NO3 (295.1208)


   

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-17-ol

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-17-ol

C18H17NO3 (295.1208)


   

(4r)-6-hydroxy-1',5-dimethyl-2,3-dihydro-1h-spiro[indene-4,3'-indole]-2',7-dione

(4r)-6-hydroxy-1',5-dimethyl-2,3-dihydro-1h-spiro[indene-4,3'-indole]-2',7-dione

C18H17NO3 (295.1208)


   

(12r,13s)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

(12r,13s)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C18H17NO3 (295.1208)


   

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-9-ol

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-9-ol

C18H17NO3 (295.1208)


   

(9r,12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-9-ol

(9r,12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-9-ol

C18H17NO3 (295.1208)


   

(2r,3r,4s,5s,6r)-2-{[(2r,3r,4r)-3,4-dihydroxypyrrolidin-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2r,3r,4r)-3,4-dihydroxypyrrolidin-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C11H21NO8 (295.1267)


   

(12r,13s)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12r,13s)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C18H17NO3 (295.1208)


   

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

C18H17NO3 (295.1208)


   

4-methoxy-6-[(1e,3e,5e,7e)-8-(1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

4-methoxy-6-[(1e,3e,5e,7e)-8-(1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

C18H17NO3 (295.1208)


   

(12s)-17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12s)-17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C18H17NO3 (295.1208)


   

(9r)-15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carbaldehyde

(9r)-15-hydroxy-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carbaldehyde

C18H17NO3 (295.1208)


   

(12s,13r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

(12s,13r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C18H17NO3 (295.1208)


   

4-[(6,7-dimethoxyisoquinolin-1-yl)methyl]phenol

4-[(6,7-dimethoxyisoquinolin-1-yl)methyl]phenol

C18H17NO3 (295.1208)


   

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C18H17NO3 (295.1208)


   

13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C18H17NO3 (295.1208)


   

2-hydroxy-1-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-9h-carbazole-3-carbaldehyde

2-hydroxy-1-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-9h-carbazole-3-carbaldehyde

C18H17NO3 (295.1208)


   

7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

C18H17NO3 (295.1208)


   

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-16-ol

C18H17NO3 (295.1208)


   

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-17-ol

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-17-ol

C18H17NO3 (295.1208)


   

4-({1-[(4-hydroxyphenyl)methyl]-2-imino-3h-imidazol-4-yl}methyl)phenol

4-({1-[(4-hydroxyphenyl)methyl]-2-imino-3h-imidazol-4-yl}methyl)phenol

C17H17N3O2 (295.1321)


   

(2e)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-phenylprop-2-enimidic acid

(2e)-n-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-3-phenylprop-2-enimidic acid

C18H17NO3 (295.1208)


   

(12s,13s)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12s,13s)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C18H17NO3 (295.1208)


   

(3s)-3-hydroxy-1-(4-hydroxyphenyl)-4-(1h-indol-3-yl)butan-2-one

(3s)-3-hydroxy-1-(4-hydroxyphenyl)-4-(1h-indol-3-yl)butan-2-one

C18H17NO3 (295.1208)


   

(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

C18H17NO3 (295.1208)


   

17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C18H17NO3 (295.1208)


   

(1z)-2-(dimethylcarbamoyl)-1-phenyleth-1-en-1-yl benzoate

(1z)-2-(dimethylcarbamoyl)-1-phenyleth-1-en-1-yl benzoate

C18H17NO3 (295.1208)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C13H17N3O5 (295.1168)


   

4-methoxy-6-[8-(1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

4-methoxy-6-[8-(1h-pyrrol-2-yl)octa-1,3,5,7-tetraen-1-yl]pyran-2-one

C18H17NO3 (295.1208)


   

(2r,3r,4s,5s,6r)-2-{[(3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3r,4r,5r)-4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C11H21NO8 (295.1267)


   

(12'r)-11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

(12'r)-11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

C18H17NO3 (295.1208)


   

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

C18H17NO3 (295.1208)


   

(12r)-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene

(12r)-18-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaene

C18H17NO3 (295.1208)


   

2-{[4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C11H21NO8 (295.1267)


   

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C18H17NO3 (295.1208)


   

6-methoxy-9-oxa-2-azapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-5(18),6,8(17),11(16),12,14-hexaen-7-ol

6-methoxy-9-oxa-2-azapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-5(18),6,8(17),11(16),12,14-hexaen-7-ol

C18H17NO3 (295.1208)


   

2-(dimethylcarbamoyl)-1-phenyleth-1-en-1-yl benzoate

2-(dimethylcarbamoyl)-1-phenyleth-1-en-1-yl benzoate

C18H17NO3 (295.1208)


   

3-hydroxy-1-(4-hydroxyphenyl)-4-(1h-indol-3-yl)butan-2-one

3-hydroxy-1-(4-hydroxyphenyl)-4-(1h-indol-3-yl)butan-2-one

C18H17NO3 (295.1208)


   
   

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-ium-11-olate

C18H17NO3 (295.1208)


   

(12s)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

(12s)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene

C18H17NO3 (295.1208)


   

2-(2h-1,3-benzodioxol-5-yl)-4-methoxy-1-methyl-4h-quinoline

2-(2h-1,3-benzodioxol-5-yl)-4-methoxy-1-methyl-4h-quinoline

C18H17NO3 (295.1208)


   

2,8-dihydroxy-1-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

2,8-dihydroxy-1-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

C18H17NO3 (295.1208)


   

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C18H17NO3 (295.1208)


   

11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

11'-methyl-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2,2'(6'),5,7'-pentaen-4-one

C18H17NO3 (295.1208)


   

(2r,3r,5r)-5-{6-[(2-hydroxyethyl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

(2r,3r,5r)-5-{6-[(2-hydroxyethyl)amino]purin-9-yl}-2-(hydroxymethyl)oxolan-3-ol

C12H17N5O4 (295.128)


   

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-15-ol

(12r)-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-15-ol

C18H17NO3 (295.1208)


   

6-hydroxy-1',5-dimethyl-2,3-dihydro-1h-spiro[indene-4,3'-indole]-2',7-dione

6-hydroxy-1',5-dimethyl-2,3-dihydro-1h-spiro[indene-4,3'-indole]-2',7-dione

C18H17NO3 (295.1208)